The activation of PPARγ in vascular smooth muscle cells resulted in improved inflammation, coronary insulin resistance, and upregulation of adiponectin receptor expression and might even improve the health of patients with T2D [84,85]. The gene discussed is PPARG; the disease is Insulin resistance.